Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Expanded the Location section by adding numerous site entries across multiple countries and states. This increases visibility of enrollment sites and provides more precise location information for potential participants.
    Difference
    4%
    Check dated 2025-12-21T21:16:46.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-30T03:32:52.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Publication notes were added clarifying that publications may relate to the study results and are automatically filled from PubMed. The page revision was updated to v3.3.1.
    Difference
    0.3%
    Check dated 2025-11-23T00:50:23.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The study location list now includes Tainan, Taiwan, 70457 instead of Tainan City, Taiwan, 70457, and the funding-status notice was removed.
    Difference
    0.1%
    Check dated 2025-11-15T17:10:17.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No significant changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-01T08:10:26.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    Added Cali, Valle del Cauca Department, Colombia, 760042 to the locations list and removed Santiago de Cali, Valle del Cauca Department, Colombia, 760042.
    Difference
    0.0%
    Check dated 2025-10-25T06:39:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.